SCHEMBL17852131

SCHEMBL17852131

CC1(C)c2c(Br)cccc2-c2ccc3ccccc3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41
DHFR P00374 3/20 0.40
ALDH1A1 P00352 4/20 0.37
CYP2A6 P11509 2/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DNMT1 P26358 1/20 0.36
CYP1A2 P05177 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3748294 0.87 MEN1 (0.52) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL19838518 0.83 DHFR (0.41) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL19421340 0.81 ALDH1A1 (0.39) ALDH1A1CDK5TYMS
SCHEMBL17852130 0.79 DNMT1 (0.37) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL16062607 0.79 MEN1 (0.45) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL29571237 0.79 MEN1 (0.45) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL19784801 0.78 ALDH1A1 (0.40) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL19797300 0.77 ALDH1A1 (0.39) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL29771097 0.76 CYP2A6 (0.40) MEN1KMT2AKDM4EMAPTTDP1
SCHEMBL29562732 0.76 CYP2A6 (0.40) MEN1KMT2AKDM4EMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023063112-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT キヤノン株式会社 2023-04-20 WO disclosed
WO-2021045590-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-03-11 WO disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 MEN1 1272/4885KMT2A 2098/4885KDM4E 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.